Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
British Journal of Urology
|
December 1, 1989
Re: Recurrence of superficial bladder carcinoma after intravesical instillation of Mitomycin-C
M K Parmar
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 1994
Pitfalls and biases in the reporting and interpretation of the results of clinical trials
M K Parmar
Statistics in Medicine
|
March 1, 1993
Monitoring clinical trials: experience of, and proposals under consideration by, the Cancer Therapy Committee of the British Medical Research Council
M K Parmar, D Machin
The New England Journal of Medicine
|
May 9, 1996
Chemotherapy for ovarian cancer
M K Parmar, J Sandercock
Journal of Epidemiology and Community Health
|
January 5, 2000
Bayesian analysis
J Grossman, M K Parmar
European Journal of Cancer & Clinical Oncology
|
December 1, 1989
A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival
M Buyse, M K Parmar
Lancet (London, England)
|
June 24, 1995
Hyperthermia in cancer treatment
D Machin, M K Parmar
Lancet (London, England)
|
January 1, 1994
Pathology review and diagnosis of cancer
D Machin, M K Parmar
Progress in Clinical and Biological Research
|
January 1, 1990
Randomised intercontinental trial of locoregional therapy with or without neoadjuvant chemotherapy
R R Hall, M K Parmar
Bulletin Du Cancer
|
February 1, 1993
The results of a quantitative overview of chemotherapy in advanced ovarian cancer: what can we learn?
L A Stewart, M K Parmar
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
British Journal of Urology
|
December 1, 1989
Re: Recurrence of superficial bladder carcinoma after intravesical instillation of Mitomycin-C
M K Parmar
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 1994
Pitfalls and biases in the reporting and interpretation of the results of clinical trials
M K Parmar
Statistics in Medicine
|
March 1, 1993
Monitoring clinical trials: experience of, and proposals under consideration by, the Cancer Therapy Committee of the British Medical Research Council
M K Parmar, D Machin
The New England Journal of Medicine
|
May 9, 1996
Chemotherapy for ovarian cancer
M K Parmar, J Sandercock
Journal of Epidemiology and Community Health
|
January 5, 2000
Bayesian analysis
J Grossman, M K Parmar
European Journal of Cancer & Clinical Oncology
|
December 1, 1989
A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival
M Buyse, M K Parmar
Lancet (London, England)
|
June 24, 1995
Hyperthermia in cancer treatment
D Machin, M K Parmar
Lancet (London, England)
|
January 1, 1994
Pathology review and diagnosis of cancer
D Machin, M K Parmar
Progress in Clinical and Biological Research
|
January 1, 1990
Randomised intercontinental trial of locoregional therapy with or without neoadjuvant chemotherapy
R R Hall, M K Parmar
Bulletin Du Cancer
|
February 1, 1993
The results of a quantitative overview of chemotherapy in advanced ovarian cancer: what can we learn?
L A Stewart, M K Parmar
Page
of 8